Kurt Graves - Net Worth and Insider Trading
Kurt Graves Net Worth
The estimated net worth of Kurt Graves is at least $30 Million dollars as of 2024-11-13. Kurt Graves is the EVP, Chief Commercial Officer of Vertex Pharmaceuticals Inc and owns about 59,880 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $29 Million. Kurt Graves is the Director of Radius Health Inc and owns about 5,500 shares of Radius Health Inc (RDUS) stock worth over $178,585. Kurt Graves is also the Director of Achillion Pharmaceuticals Inc and owns about 22,709 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $153,513. Details can be seen in Kurt Graves's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt Graves has not made any transactions after 2019-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kurt Graves
Kurt Graves Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt Graves owns 5 companies in total, including Seres Therapeutics Inc (MCRB) , Radius Health Inc (RDUS) , and Achillion Pharmaceuticals Inc (ACHN) among others .
Click here to see the complete history of Kurt Graves’s form 4 insider trades.
Insider Ownership Summary of Kurt Graves
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2015-11-09 | director |
| RDUS | Radius Health Inc | 2019-04-16 | director |
| ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | director |
 | | 2015-12-08 | director |
| | 2009-10-19 | EVP & Chief Commercial Officer |
Kurt Graves Latest Holdings Summary
Kurt Graves currently owns a total of 3 stocks. Among these stocks, Kurt Graves owns 59,880 shares of Vertex Pharmaceuticals Inc (VRTX) as of October 19, 2009, with a value of $29 Million and a weighting of 98.88%. Kurt Graves owns 5,500 shares of Radius Health Inc (RDUS) as of April 16, 2019, with a value of $178,585 and a weighting of 0.6%. Kurt Graves also owns 22,709 shares of Achillion Pharmaceuticals Inc (ACHN) as of June 11, 2012, with a value of $153,513 and a weighting of 0.52%.
Latest Holdings of Kurt Graves
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2009-10-19 | 59,880 | 490.00 | 29,341,200 |
| RDUS | Radius Health Inc | 2019-04-16 | 5,500 | 32.47 | 178,585 |
| ACHN | Achillion Pharmaceuticals Inc | 2012-06-11 | 22,709 | 6.76 | 153,513 |
Holding Weightings of Kurt Graves
Kurt Graves Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt Graves has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 1,500 shares on October 19, 2009, which brought Kurt Graves around $52,050.
According to the SEC Form 4 filings, Kurt Graves has made a total of 0 transactions in Radius Health Inc (RDUS) over the past 5 years. The most-recent trade in Radius Health Inc is the sale of 4,800 shares on April 16, 2019, which brought Kurt Graves around $107,136.
According to the SEC Form 4 filings, Kurt Graves has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on June 11, 2012, which brought Kurt Graves around $0.
Insider Trading History of Kurt Graves
- 1
Kurt Graves Trading Performance
Kurt Graves Ownership Network
Ownership Network List of Kurt Graves
Ownership Network Relation of Kurt Graves
Kurt Graves Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Kurt Graves is the director of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Kurt Graves made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,175 shares made by Teresa L. Young , a net sale of 33,802 shares made by Eric D. Shaff , and a net sale of 14,878 shares made by Moltke Lisa Von .
In summary, during the past 3 months, insiders sold 31,451 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,451 shares. During the past 18 months, 133,982 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,982 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Kurt Graves Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt Graves. You might contact Kurt Graves via mailing address: C/o Achillion Pharmaceuticals Inc., 300 George Street, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
